Search

everythinglearnresearchcommunity

for

Search:↓

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Minoxidil was more effective than laser therapy for hair loss, and the report also highlighted the need for more research on PRP for a different hair loss condition, the impact of social media on alopecia views, and a warning on turmeric causing nail discoloration.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Zaleya pentandra extracts, especially acetone, may be useful for new medicines and food industry applications.

The document concludes that personalized treatment, including lifestyle changes and medication, is essential for managing PCOS in teenagers, while also addressing their psychological well-being.

AA–TF#15 significantly promotes hair regrowth and could be an effective treatment for androgenic alopecia.

Solidified SEDDS improve drug stability and bioavailability better than liquid SEDDS.

Some natural remedies may help with hair regrowth, but more research is needed to confirm their effectiveness and safety.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

More research is needed to understand how testosterone is maintained in adult males.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Turkish pregnant women commonly experienced skin issues like itching and acne, and doctors mainly used topical treatments due to safety concerns during pregnancy.

New treatments for skin diseases are more effective and patient-friendly, but many still lack a cure.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Gray hair can potentially be reversed, leading to new treatments.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.